Patent · US Active

Itraconazole analogs and use thereof

US9346791B2 · kind B2 · utility

9Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2012
Grant dateMay 24, 2016
Priority date—
Expiry dateSep 7, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/506
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are Itraconazole analogs. Also provided herein are methods of inhibition of Hedgehog pathway, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, angiogenesis and treatment of disease with Itraconazole analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.